Reaction
Acquired Porphyria reporting signals
As of the last recalculation, Acquired Porphyria appears in 70 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC POTASSIUM, FILM COATED (PRR 563.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diclofenac Potassium, Film Coated | 13 | 563.9 | 564.8 |
| Diclofenac Potassium Tablets | 13 | 563.5 | 564.4 |
| Diclofenac Potassium | 13 | 439.1 | 439.6 |
| Pseudoephedrine Hydrochloride | 11 | 377.5 | 377.9 |
| Hydrocortisone Sodium Succinate | 10 | 368.8 | 369.2 |
| Pseudoephedrine Hcl | 11 | 352.0 | 352.4 |
| Naproxen Sodium Tablet, Coated | 12 | 317.8 | 318.1 |
| Naproxen Sodium, Coated Tablets | 12 | 317.8 | 318.1 |
| Naproxen Sodium 220Mg | 12 | 317.4 | 317.7 |
| Fosaprepitant Dimeglumine | 11 | 282.0 | 282.2 |
| Tofacitinib Citrate | 10 | 264.4 | 264.6 |
| Desoximetasone | 12 | 225.8 | 226.0 |
| Aprepitant | 11 | 210.0 | 210.1 |
| Isopropyl Alcohol | 15 | 167.7 | 167.8 |
| Alcohol | 15 | 146.0 | 146.0 |
| Cortisone Acetate | 5 | 129.6 | 129.7 |
| Sarilumab | 7 | 87.4 | 87.5 |